Navigation Links
Codexis Reports First Quarter 2011 Results
Date:5/5/2011

REDWOOD CITY, Calif., May 5, 2011 /PRNewswire/ -- Codexis, Inc. (NASDAQ: CDXS) today announced financial results for the first quarter ended March 31, 2011.  

First Quarter Financial Highlights:Revenue: For the first quarter of 2011, the company reported revenues of $31.0 million, an increase of 21% from $25.7 million in the first quarter of 2010.  Product revenue of $12.9 million increased 106% over the same time period driven by more than $5 million in sales of the boceprevir intermediate to be used in Merck's investigational Hepatitis C drug trade named Victrelis.  Collaborative R&D revenue of $2.7 million increased from $0.7 million in the first quarter of 2010, driven mainly by funded research for our carbon capture program.

Operating Expenses:  Research and development expenses in the first quarter of 2011 were $13.8 million, compared to $13.0 million for the first quarter of 2010.  The increase was primarily due to an increase in amortization related to intellectual property purchased from Maxygen, Inc. in the fourth quarter of 2010 and higher depreciation and stock compensation expenses. Selling, general and administrative expenses in the first quarter of 2011 increased to $9.0 million compared to $8.6 million over the same period of 2010, driven by higher stock compensation expense and higher compensation expense due to headcount increases.

Net Loss:  Net loss was ($3.5) million, or ($0.10) per share, based on 35.1 million weighted average common shares outstanding in the first quarter of 2011.   This compares to a net loss of ($1.4) million or ($0.50) per share during the first quarter of 2010.  

Adjusted EBITDA:  On a non-GAAP basis, Adjusted EBITDA decreased from $2.8 million in the first quarter of 2010 to $1.8 million in 2011. Adjusted EBITDA is calculated by adjusting net loss for ne
'/>"/>

SOURCE Codexis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Former Senator Byron Dorgan Elected to Codexis Board
2. Codexis Reports Fourth Quarter and Full Year 2010 Results
3. Codexis Grows Revenue 35 Percent in Third Quarter; Raises 2010 Outlook
4. Codexis Names Vonnie Estes to New Technology Strategic Planning VP Role
5. Codexis R&D Productivity Panels Also Used By Roche
6. Codexis Names Lori Giver VP Systems Biology
7. Codexis, Teva in Licensing Agreement Final
8. Codexis Names Vice President, Intellectual Property
9. Codexis, Arch Announce Expanded Collaboration
10. Vanda Pharmaceuticals Reports First Quarter 2011 Results
11. Reportlinker Adds Genetics Reports Bundle
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... FRANCISCO , March 31, 2015  Sonoa Health, ... Australia , has developed a world-first consumer health ... records, medication prescriptions, wearable devices and more. ... Stewart as its CEO, who brings to the ... corporate advisory, which has included working closely with the ...
(Date:3/31/2015)... DALLAS and NEW YORK ... Inc. (NASDAQ: PTBI ), a biopharmaceutical company ... products, announced today that its Korean marketing partner, ... received marketing approval in Korea from the country,s ... the Korea Testing & Research Institute (KTR) for ...
(Date:3/31/2015)... 31, 2015 Diasome Pharmaceuticals, Inc. ( ... Inc., that a United States patent has recently been ... , Entitled “Lipid Construct for Delivery of ... matter claims related to the use of Diasome’s proprietary ... injected insulin to more effectively reach the liver’s metabolic ...
(Date:3/30/2015)... , March 30, 2015  Multiple new research abstracts ... several important health factors. From their impact on colon ... positive effect on both gut health and vascular health, ... detail our latest understanding of walnuts, inner workings. Running ... , this annual meeting attracts an international audience ...
Breaking Biology Technology:Investment Banker Appointed CEO of Australian Health Tech Start-Up 2Investment Banker Appointed CEO of Australian Health Tech Start-Up 3PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 2PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 3Diasome Pharmaceuticals, Inc. Announces Notice of Allowance from US PTO for Liver Targeting System for Insulin 2New Findings Support the Benefits of Eating Walnuts on Overall Health 2New Findings Support the Benefits of Eating Walnuts on Overall Health 3New Findings Support the Benefits of Eating Walnuts on Overall Health 4
... Purdue University, working with the U.S. Air Force, have ... harsh conditions inside jet engines to detect when critical ... The devices are an example of an emerging technology ... machines that combine electronic and mechanical components on a ...
... Nabi,Biopharmaceuticals (Nasdaq: NABI ) (the "Company") announced ... Co., two of the nation,s leading,independent proxy advisory ... the Company,s proposed sale of its Biologics strategic,business ... Biotest,Pharmaceuticals Corporation, a wholly owned subsidiary of Biotest ...
... Bioscience, Inc., (http://www.pasteuriabio.com ), a Florida biotech company ... problem, announced,today that David N. Duncan, Ph.D., has ... Duncan has also been elected to the Company,s ... will remain active with the,Company as its Chief ...
Cached Biology Technology:Purdue creating wireless sensors to monitor bearings in jet engines 2Purdue creating wireless sensors to monitor bearings in jet engines 3RiskMetrics Group (ISS) and Glass Lewis & Co. Support Nabi Biopharmaceuticals' Proposed Asset Sale 2RiskMetrics Group (ISS) and Glass Lewis & Co. Support Nabi Biopharmaceuticals' Proposed Asset Sale 3Pasteuria Bioscience Taps New CEO David N. Duncan 2Pasteuria Bioscience Taps New CEO David N. Duncan 3
(Date:3/10/2015)...  Continuing its 167-year history of offering the Best, ... The Eye Scanning Password Authenticator , a device that ... websites or sensitive data. Employing the same ... the device has a small camera that scans and ... converting them into an encrypted ID that cannot be ...
(Date:3/10/2015)...   Tute Genomics , pioneer in affordable, accurate ... sequencing company PrimBio Research Institute to be ... panel interpretation. PrimBio, a certified Life Technologies ... technologies to support the work of experts on the ... types of exome sequencing services: 1) Targeted Exome and ...
(Date:3/5/2015)... -- In Brazil , cloud computing is ... solutions and 42 percent planning to invest in them by ... of the companies will be investing in these solutions for ... in the region are currently opting for the private cloud ... significant attention in the coming years. This trend is in ...
Breaking Biology News(10 mins):Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 2PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 3Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 2Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 3Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 4
... darkened meadow west of Boston, Tufts University biologists are ... life of fireflies. , For the first time, researchers ... light ?previously shown in one species to indicate superior ... to provide misinformation to prospective mates. In other words, ...
... mays) in Illinois, a field worker noticed a plant so ... species. Its "peculiarly shaped ear" was "laid aside as a ... Latin ramosus, "having many branches"). Due to the alteration of ... the tassel of the plant were more highly branched than ...
... at Nihon Nohyaku Co., Ltd., Bayer CropScience and DuPont ... show promise as a safer and more effective way ... insecticides, which represent the first synthetic compounds designed to ... may also help tackle the growing problem of insecticide ...
Cached Biology News:Tufts researchers shine light on firefly mysteries 2The genetic origins of corn on the cob 2Novel compounds show promise as safer, more potent insecticides 2
Umbilical cord blood CD14+ Monocytes, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Monocytes, B Cells and NK Cells...
Human peripheral blood CD8+ T cells, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood PBMC and T Cells...
Human peripheral blood CD56+ NK cells, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Monocytes, B Cells, NK Cells and Stem Cells...
Human monocyte-derived dendritic cells, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Dendritic Cells and EPCs...
Biology Products: